Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06004700 · ClinicalTrials.gov registry record · NA

Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits

A NA study of Psoriatic Arthritis and Arthritis, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
278
Enrollment target
1
Study location

NCT06004700: Active NA study of Psoriatic Arthritis and Arthritis, sponsored by Brigham and Women's Hospital.

NCT06004700 is a NA study of Psoriatic Arthritis and Arthritis that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 278 participants, below the 847-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06004700, a NA study of Psoriatic Arthritis and Arthritis, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
278 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this proposal is to test version 3.0 of the Arthritis smartphone app in a 12-month interrupted time series analysis (ITSA) design which will allow us to observe possible differences in visit frequency between the pre-and post-intervention periods as well as between the concurrent control group and those who receive the app. Our central hypothesis is that introduction of the app will reduce visit numbers per month in the group receiving the app, compared with a concurrent control group.

Primary Outcome

The differences in visit frequency, between the pre-and post-intervention periods and between the concurrent control group and those who receive the app

Interventions

  • OTHER Mobile Application

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 278 participants
Start Date 2024-04-11
Est. Completion 2026-10-01
Phase NA
Brigham and Women's Hospital

937 total trials

What the registry record for NCT06004700 still lists

NCT06004700 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 847-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (67% lower).

The record links to 2 conditions, with Psoriatic Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Mobile Application is the first listed.

NCT06004700 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06004700 about?

NCT06004700 is a clinical study titled "Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits". The overall objective of this proposal is to test version 3.0 of the Arthritis smartphone app in a 12-month interrupted time series analysis (ITSA) design which will allow us to observe possible differences in visit frequency between the pre-and post-intervention periods as well as between the concu...

What is the current status of trial NCT06004700?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 278 participants. The study started on 2024-04-11. Estimated completion is 2026-10-01.

What conditions does trial NCT06004700 study?

This clinical trial studies the following conditions: Psoriatic Arthritis, Arthritis.

What interventions are being tested in trial NCT06004700?

The interventions under investigation include: Mobile Application (OTHER).

Who is sponsoring clinical trial NCT06004700?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06004700 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psoriatic Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06004700's enrollment target sits among peer trials

278 24th of 48 higher than 25 of 48 other Psoriatic Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psoriatic Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04586959 · 278 participants · NA

    Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

  • NCT05010148 · 278 participants · Phase 3

    A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

  • NCT05489237 · 278 participants · Phase 1

    First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

  • NCT05965245 · 278 participants · NA

    Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06004700, the US trial registry maintained by the National Library of Medicine. NCT06004700 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.